Morgan Stanley raised the firm’s price target on Globe Life to $83 from $66 and keeps an Equal Weight rating on the shares. In Q2, most life insurance companies reported earnings that exceeded expectations, the analyst tells investors. Despite the strong results, the firm remains incrementally negative on life insurers due to the potential compression on spread-based income products and market volatility that has emerged in the past few weeks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- GLOBE LIFE INC. DECLARES DIVIDEND
- Globe Life price target raised to $90 from $80 at Truist
- Globe Life price target raised to $106 from $105 at Piper Sandler
- Globe Life attractive risk/reward masked by uncertainty, says JPMorgan
- Globe Life sees fiscal 2024 operating EPS $11.80-$12.10, consensus $11.75
